Abstract:Objective To investigate the difference in serum miRNA-124 expression among patients with vascular dementia and its significance.Methods Sixty-eight patients admitted to our hospital for vascular dementia from January 2018 to May 2019 were assigned to observation group, while 50 healthy volunteers were used as control. Before treatment, general information and the relative expression level of miRNA-124 were evaluated in the observation group and the control group. The change in the relative expression level of miRNA-124 was analyzed after 3 months of treatment. According to treatment outcomes, the patients were divided into good outcome group and poor outcome group. The relative expression level of miRNA-124 was compared between the two groups.Results The relative expression level of miRNA-124 was significantly higher in the observation group than in the control group before treatment (P<0.005). After 3 months of treatment, the relative expression level of miRNA-124 was significantly reduced in the observation group (P<0.015). There were no significant differences in sex, age, or weight between the good outcome group and the poor outcome group (P>0.05); however, there were significant differences in hypertension, hyperlipidemia, and miRNA-124 between the two groups (P<0.05). In the prediction of prognosis for vascular dementia, the areas under the receiver operating characteristic curve were 0.742, 0.705, and 0.821 for hyperlipidemia, hypertension, and the relative serum expression of miRNA-124, respectively; the cut-off values determined by the maximum Youden index were 5.220(sensitivity=60.00%, specificity=85.70%), 1.965(sensitivity=75.00%, specificity=69.00%), and 4.225(sensitivity=80.00%, specificity=78.60%) for hyperlipidemia, hypertension, and the relative serum expression level of miRNA-124, respectively.Conclusions The expression level of miRNA-124 may be an indicator of poor prognosis in patients with vascular dementia.